Ausgabe Sonderheft 1/2019
Lp(a) – Update 2018
Inhalt (9 Artikel)
Open Access
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region
Florian Kronenberg
Open Access
Lipoprotein(a) and mortality—a high risk relationship
Reinhard Klingel, Andreas Heibges, Cordula Fassbender
Open Access
Lipoprotein(a)—an interdisciplinary challenge
U. Julius, S. Tselmin, U. Schatz, S. Fischer, S. R. Bornstein
Open Access
Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?
Alexander Heinrich Nave, Arnold von Eckardstein
Open Access
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
V. J. J. Schettler, C. L. Neumann, C. Peter, T. Zimmermann, U. Julius, B. Hohenstein, E. Roeseler, F. Heigl, P. Grützmacher, H. Blume, R. Klingel, A Vogt
Open Access
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Norbert Weiss, Ulrich Julius
Open Access
PCSK9 Inhibitor
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
U. Julius, S. Tselmin, U. Schatz, S. Fischer, S. R. Bornstein